Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?

Marijke B. Coomans*, Linda Dirven, Neil K. Aaronson, Brigitta G. Baumert, Martin Van Den Bent, Andrew Bottomley, Alba A. Brandes, Olivier Chinot, Corneel Coens, Thierry Gorlia, Ulrich Herrlinger, Florence Keime-Guibert, Annika Malmstroem, Francesca Martinelli, Roger Stupp, Andrea Talacchi, Michael Weller, Wolfgang Wick, Jaap C. Reijneveld, Martin J. B. Taphoorn

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1447-1457
Number of pages11
JournalNeuro-oncology
Volume21
Issue number11
DOIs
Publication statusPublished - Nov 2019

Keywords

  • EORTC QLQ-C30
  • glioma
  • health-related quality of life
  • QLQ-BN20
  • symptom
  • symptom cluster
  • QUALITY-OF-LIFE
  • TEMOZOLOMIDE CHEMOTHERAPY
  • EUROPEAN-ORGANIZATION
  • CLINICAL-TRIALS
  • CANCER-PATIENTS
  • OPEN-LABEL
  • RADIOTHERAPY
  • GLIOBLASTOMA
  • REHABILITATION
  • SURVIVAL

Cite this

Coomans, M. B., Dirven, L., Aaronson, N. K., Baumert, B. G., Van Den Bent, M., Bottomley, A., Brandes, A. A., Chinot, O., Coens, C., Gorlia, T., Herrlinger, U., Keime-Guibert, F., Malmstroem, A., Martinelli, F., Stupp, R., Talacchi, A., Weller, M., Wick, W., Reijneveld, J. C., & Taphoorn, M. J. B. (2019). Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status? Neuro-oncology, 21(11), 1447-1457. https://doi.org/10.1093/neuonc/noz118